MabThera (Inopha)
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.
Name of the medicinal product | 1. MabThera 100 mg Konzentrat zur Herstellung einer Infusionslösung 2. MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung |
---|---|
Marketing authorisation number(s) | 1. EU/1/98/067/001 2. EU/1/98/067/002 |
Marketing authorisation holder | Roche Registration Limited Paralleldistribution: INOPHA GmbH |
Batch number(s) | 1. MabThera 100 mg: H0101B03, H0111B03, H0115B05, H0121B10, H0122B03, H0122B07, H0128B01, H0136B03 2.MabThera 500 mg: H0637B01, H0656B01, H0698B01, N3610B02 |
Classification of the recall | 2 |
BASG reference number | INS - 640.001 - 108 7 |
Further inquiry note
Page last modified:
12/07/2022